Quantcast
Home > Quotes > CDXC

ChromaDex Corporation Common Stock (CDXC) Quote & Summary Data

CDXC 
$3.49
*  
0.09
2.65%
Get CDXC Alerts
*Delayed - data as of Nov. 16, 2018  -  Find a broker to begin trading CDXC now
Exchange:NASDAQ
Industry: Consumer Durables
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
9.25
Today's High / Low
$ 3.50 / $ 3.38
Share Volume
73,457
50 Day Avg. Daily Volume
199,096
Previous Close
$ 3.40
52 Week High / Low
$ 7.24 / $ 3.19
Market Cap
192,307,669
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
2.18

Intraday Chart

Shares Traded

Share Volume:
73,457
50 Day Avg. Daily Volume:
199,096

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.63

Trading Range

The current last sale of $3.49 is 9.40% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.50 $ 7.24
 Low: $ 3.38 $ 3.19

Company Description (as filed with the SEC)

Unless otherwise indicated or the context otherwise requires, references to the "Company", "ChromaDex", "we", "us" and "our" refer to ChromaDex Corporation and its consolidated subsidiaries. Company Overview ChromaDex is a science-based integrated nutraceutical company devoted to pioneering technologies that improve the way people age. ChromaDex engages with and supports many of the world's leading research institutions and scientists that are diligently working to understand the full potential of nicotinamide adenine dinucleotide ("NAD") and its impact on human health. NAD is an essential coenzyme and a key regulator of cellular metabolism. Best known for its role in cellular adenosine triphosphate ("ATP") production, NAD is now thought to play an important role in healthy aging. Many cellular functions related to health and healthy aging are sensitive to levels of locally available NAD and this represents an active area of research in the field of NAD.  ... More ...  


Risk Grade

Where does CDXC fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.38
Open Date:
Nov. 16, 2018
Close Price:
$ 3.40
Close Date:
Nov. 16, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x